Sympathetic and sensory axons invade the brains of nerve growth factor transgenic mice in the absence of p75NTR expression.
Collateral sprouting, a nerve growth factor (NGF)-mediated growth response of undamaged peripheral axons, can be divided into reparative and aberrant axonal growth. We have previously shown that aberrant growth occurs in transgenic mice overexpressing NGF centrally under the control of the glial fibrillary acidic protein promoter. Both sympathetic and sensory fibers, stained immunohistochemically for tyrosine hydroxylase and calcitonin gene-related peptide, respectively, invade the cerebellum of postnatal transgenic mice, whereas no such axons are seen in age-matched wild-type cerebellum. Recent examination of mice possessing a null mutation for p75NTR has suggested that axon growth may be influenced by the functional expression of this receptor. To address the potential role of p75NTR in axon growth, we have generated a new line of hybrid mice overexpressing NGF but lacking functional p75NTR expression. Postnatal (day 14) hybrid cerebellum possessed fewer aberrant sensory and sympathetic fibers compared to their age-matched transgenic counterparts. By adulthood, however, hybrid cerebellum displayed a robust plexus of axons stained immunohistochemically for calcitonin gene-related peptide and tyrosine hydroxylase. No neuronal or nonneuronal localization of p75NTR-immunoreactive elements was observed in postnatal and adult hybrid cerebellum. Interestingly, sympathetic axons within the hybrid cerebellum displayed a markedly reduced axon density and staining intensity for NGF, suggesting a possible alteration in axonal sequestration of NGF. These results show that p75NTR is not vital for new growth of NGF-sensitive sympathetic and sensory axons and that immunohistochemical detection of NGF at sympathetic axons requires the functional expression of p75NTR.
Coome
G E
GE
Department of Anatomy and Cell Biology, Queen's University, Kingston, Ontario, Canada.
Elliott
J
J
Kawaja
M D
MD
D000818:Animals; D001369:Axons / Q000502:physiology*; D001921:Brain / Q000502:physiology*; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism; D003714:Denervation; D005154:Facial Nerve / Q000502:physiology; D005260:Female; D007150:Immunohistochemistry; D051379:Mice; D008818:Mice, Neurologic Mutants; D008822:Mice, Transgenic / Q000235:genetics*; D009412:Nerve Fibers / Q000378:metabolism / Q000502:physiology; D009414:Nerve Growth Factors / Q000235:genetics* / Q000378:metabolism; D009416:Nerve Regeneration / Q000502:physiology; D009474:Neurons / Q000502:physiology*; D009475:Neurons, Afferent / Q000502:physiology*; D020800:Receptor, Nerve Growth Factor; D017475:Receptors, Nerve Growth Factor / Q000172:deficiency* / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000166:cytology / Q000502:physiology*; D014018:Tissue Distribution
D009414:Nerve Growth Factors; D020800:Receptor, Nerve Growth Factor; D017475:Receptors, Nerve Growth Factor; D015740:Calcitonin Gene-Related Peptide